Skip to content
About Us
Oncolytic Viruses
Immunotherapy Combinations
R&D Facility
Team
Company News
Corporate Investor Deck
Our Technology
IVX037
IVX055
Pipeline
Scientific Presentations
Pre-clinical / discovery
Clinical
Therapeutic Strategy
Innovent Collaboration
Pipeline
Leadership Team
Board
Management Team
Investor Centre
Corporate Deck
Company Announcements
In the News
ESG
Recruitment
Contact Us
About Us
Oncolytic Viruses
Immunotherapy Combinations
R&D Facility
Team
Company News
Corporate Investor Deck
Our Technology
IVX037
IVX055
Pipeline
Scientific Presentations
Pre-clinical / discovery
Clinical
Therapeutic Strategy
Innovent Collaboration
Pipeline
Leadership Team
Board
Management Team
Investor Centre
Corporate Deck
Company Announcements
In the News
ESG
Recruitment
Contact Us
News
July 13, 2021
Bioshares Interview: Malcolm McColl, CEO ImmVirX
Bioshares recently interviewed our CEO Malcolm McColl as part of their latest edition.
You can read the full story in PDF format
here
.
Prev
Previous
Next
Next